Skip to main content

Advertisement

Table 1 Characteristics of the study groups (x ± SD)

From: NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer

Parameter Control group D C DC
No. pts. 20 20 19 19
Sex, M/F 10/10 10/10 10/9 9/10
Age, years 55.5 ± 8.1 55.4 ± 7.8 56.4 ± 8.0 56.0 ± 8.0
BMI, kg/m2 26.6 ± 2.9 27.0 ± 5.1 25.9 ± 3.3 26.3 ± 2.9
WHR, m/m 0.88 ± 0.08 0.89 ± 0.08 0.88 ± 0.09 0.87 ± 0.08
T2D, years 6.5 ± 3.1 6.7 ± 3.1
FPG, mmol/l 5.3 ± 0.7 7.2 ± 0.8* 5.5 ± 0.8 7.5 ± 0.9*
HbA1c,  % 5.4 ± 0.8 7.2 ± 0.7* 5.5 ± 0.7 7.3 ± 0.9*
Insulin, mU/l 7.8 ± 3.5 14.2 ± 1.6* 8.2 ± 4.6 21.7 ± 8.1*
HOMA-IRa 1.89 ± 1.05 4.46 ± 1.8* 1.99 ± 1.2 6.96 ± 2.8*
  1. BMI body mass index, WHR waist/hip ratio, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose
  2. Comparing the parameters of various study groups was made relative to the control group; * P < 0.01
  3. aHOMA-IR index was calculated on the basis of HOMA formula = fasting insulin (mU/l) × fasting glucose (mmol/l)/22.5